Capital International Purchases Substantial Shares in AbbVie

AI-generated NewsSnap summary based on source reporting.
Published: 2026-06-07
Category: business
Source: MarketBeat
Original source

Capital International Inc. has completed the acquisition of 63,433 shares in biopharmaceutical firm AbbVie Inc. This investment comes as AbbVie reported a 12.4% rise in quarterly revenue year-over-year. Analysts are projecting AbbVie to achieve 14.3 earnings per share for the current fiscal year.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai